Updates on the Genetics and Molecular Subtypes of Urothelial Carcinoma and Select Variants
- 1 December 2018
- journal article
- review article
- Published by Elsevier in Surgical Pathology Clinics
- Vol. 11 (4) , 713-723
Abstract
No abstract availableKeywords
Funding Information
- Marie-Josée and Henry R. Kravis Center for Molecular Oncology
This publication has 42 references indexed in Scilit:
- DNA Repair Deficiency and Immunotherapy ResponseJournal of Clinical Oncology, 2018
- Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial CancersJournal of Clinical Oncology, 2018
- Treatment resistance in urothelial carcinoma: an evolutionary perspectiveNature Reviews Clinical Oncology, 2018
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder CancerCell, 2017
- DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial CarcinomaClinical Cancer Research, 2017
- The evolving genomic landscape of urothelial carcinomaNature Reviews Urology, 2017
- Genomic characterization of response to chemoradiation in urothelial bladder cancerCancer, 2016
- Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumorsNature Genetics, 2016
- Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial CarcinomaCancer Discovery, 2014
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline ChemotherapyCancer Cell, 2014